Rajendran, Praveen individual record
Associate Professor
selected publications
Academic Articles10
  • Kapoor, S., Gustafson, T., Zhang, M., Chen, Y., Li, J., Nguyen, N., ... Dashwood, R. H. (2021). Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells.. Cancers (Basel). 13(6), 1438-1438.
    doi badge pubmed badge
  • Ulusan, A. M., Rajendran, P., Dashwood, W. M., Yavuz, O. F., Kapoor, S., Gustafson, T. A., ... Dashwood, R. H. (2021). Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).. Cancer Prev Res (Phila). 14(3), 325-336.
    doi badge pubmed badge
  • Johnson, G. S., Rajendran, P., & Dashwood, R. H. (2020). CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis.. Cancer Sci. 111(10), 3416-3425.
    doi badge pubmed badge
  • Okonkwo, A., Mitra, J., Johnson, G. S., Li, L. i., Dashwood, W. M., Hegde, M. L., ... Rajendran, P. (2018). Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs.. Mol Nutr Food Res. 62(18), e1800228-1800228.
    doi badge pubmed badge
  • Johnson, G. S., Li, J., Beaver, L. M., Dashwood, W. M., Sun, D., Rajendran, P., ... Dashwood, R. H. (2017). A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells.. Mol Nutr Food Res. 61(4), 1600769-1600769.
    doi badge pubmed badge
Conference Papers5
  • Kapoor, S., Gustafson, T., Zhang, M., Chen, Y., Li, J., Nguyen, N., ... Dashwood, R. (2021). Combined deacetylase and bromodomain inhibition downregulates ERCC2 and suppresses growth of metastatic colon cancer cells.. CANCER RESEARCH. 81(13),
  • Demirhan, Y. E., Rajendran, P., Dashwood, W., Kapoor, S., Ulusan, A., Tripathi, C., ... Dashwood, R. (2021). Optimized Lower Dose Combinations of Sulindac Plus Erlotinib Sustained Antitumor Efficacy and Reduced Toxicity in a Preclinical Model of FAP. AMERICAN JOURNAL OF GASTROENTEROLOGY. 116, S138-S138.
  • Rajendran, P., Ulusan, A., Dashwood, W., Kapoor, S., Mohammed, A., Sei, S., ... Dashwood, R. H. (2020). Abstract 21: Optimization of dosing regimens of sulindac in combination with erlotinib for small intestine and colorectal cancer prevention. Molecular and Cellular Biology / Genetics, Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. 80(16), 21-21.
    doi badge
  • Rajendran, P., Damiani, E., Wang, S., Dashwood, W., & Dashwood, R. H. (2020). Abstract 3477: Dietary polyphenols as epigenetic ‘reader' inhibitors. Molecular and Cellular Biology / Genetics, Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. 80(16), 3477-3477.
    doi badge
  • Ulusan, A., Rajendran, P., Dashwood, W., Mohammed, A., Sei, S., Brown, P. H., Vilar-Sanchez, E., & Dashwood, R. H. (2019). Abstract 5074: Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP. Cancer Research. 79(13_Supplement), 5074-5074.
    doi badge
Email
prajendran@tamu.edu
First Name
Praveen
Last Name
Rajendran
mailing address
Texas A&M Health Science Center; Ibt - Cedp - Dashwood; 1201 TAMUS
Houston, TX 77030-3303
USA